Cargando…

Comparison of Different Promoter Methylation Assays in Breast Cancer

Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suijkerbuijk, Karijn P. M., Pan, Xiaojuan, van der Wall, Elsken, van Diest, Paul J., Vooijs, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2010
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605677/ https://www.ncbi.nlm.nih.gov/pubmed/20978321 http://dx.doi.org/10.3233/ACP-CLO-2010-0542

Ejemplares similares

Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer
por: van Diest, Paul J., et al.
Publicado: (2010)

Conditional Inactivation of HIF-1 Using Intrabodies
por: Groot, Arjan J., et al.
Publicado: (2008)

Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Nipple Aspirate Fluid at a Glance
por: Patuleia, Susana I. S., et al.
Publicado: (2021)

DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection
por: de Groot, Jolien S., et al.
Publicado: (2016)

No Amplifications of Hypoxia-Inducible Factor-1α Gene in Invasive Breast Cancer: A Tissue Microarray Study
por: Vleugel, Marije M., et al.
Publicado: (2004)

Genomic Profiling by Array Comparative Genomic Hybridization Reveals Novel DNA Copy Number Changes in Breast Phyllodes Tumours
por: Kuijper, Arno, et al.
Publicado: (2009)

COMMD1 Promotes pVHL and O(2)-Independent Proteolysis of HIF-1α via HSP90/70
por: van de Sluis, Bart, et al.
Publicado: (2009)

Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)

Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?
por: Patuleia, Susana I. S., et al.
Publicado: (2022)

Primary prevention of breast cancer in high-risk women by monitoring epigenetic changes in nipple aspirates
por: van Diest, PJ, et al.
Publicado: (2009)

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005)

Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression
por: Hyseni, Agon, et al.
Publicado: (2011)

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

Hypoxia‐Induced Acidification Causes Mitoxantrone Resistance Not Mediated by Drug Transporters in Human Breast Cancer Cells
por: Greijer, A. E., et al.
Publicado: (2005)

Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
por: Lacle, Miangela M., et al.
Publicado: (2013)

Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2013)

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
por: van Voss, Marise R Heerma, et al.
Publicado: (2010)

Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value
por: Lacle, Miangela M., et al.
Publicado: (2015)

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
por: Moelans, Cathy B., et al.
Publicado: (2018)

The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum
por: Patuleia, Susana I. S., et al.
Publicado: (2020)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
por: Moelans, Cathy B, et al.
Publicado: (2019)

Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related
por: Bos, Reinhard, et al.
Publicado: (2004)

Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports
por: van Dooijeweert, Carmen, et al.
Publicado: (2020)

Immunophenotyping invasive breast cancer: paving the road for molecular imaging
por: Vermeulen, Jeroen F, et al.
Publicado: (2012)

Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer
por: Bol, Guus M., et al.
Publicado: (2013)

Expression Pattern of a Homeotic Gene, HOXA5, in Normal Breast and in Breast Tumors
por: Henderson, Gregory S., et al.
Publicado: (2006)

Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features
por: Koop, Esther A, et al.
Publicado: (2009)

HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
por: Moelans, Cathy B., et al.
Publicado: (2009)

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
por: Ercan, Cigdem, et al.
Publicado: (2012)

Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study
por: Moelans, Cathy B., et al.
Publicado: (2010)

FER kinase promotes breast cancer metastasis by regulating α(6)- and β(1)-integrin-dependent cell adhesion and anoikis resistance
por: Ivanova, I A, et al.
Publicado: (2013)

Chromosome 17 copy number changes in male breast cancer
por: Lacle, Miangela M., et al.
Publicado: (2015)

Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
por: Dackus, Gwen M H E, et al.
Publicado: (2021)

The potential of hypoxia markers as target for breast molecular imaging – a systematic review and meta-analysis of human marker expression
por: Adams, Arthur, et al.
Publicado: (2013)

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
por: Dackus, Gwen M. H. E., et al.
Publicado: (2020)

EGFR and K-ras Mutation Analysis in Non-Small Cell Lung Cancer: Comparison of Paraffin Embedded versus Frozen Specimens
por: Gallegos Ruiz, Mariëlle I., et al.
Publicado: (2007)

Cytoplasmic DDX3 as prognosticator in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2021)

Goodbye Analytical Cellular Pathology, Hello Cellular Oncology!
por: van Diest, Paul J.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_qjj2mdvi0vf180ga9c75b5s1pm